Tag: Richard Mulligan

  • Science & Tech

    ‘Any patient with any disease’

    Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”

    3–5 minutes
    Chad Cowen
  • Health

    Sickle cell disease cured in mouse model

    Sickle cell disease is a blood disorder caused by a single mutation in the beta-globin gene that results in the substitution of one amino acid. This small error is enough to change the properties of the protein: when “sickled,” the blood’s hemoglobin dumps its oxygen in tissues, and it tends to stick to itself. This…

    1–2 minutes